70 related articles for article (PubMed ID: 33813620)
1. Does Familial Mediterranean Fever Provoke Atherosclerosis in Children? Evaluation of Arterial Stiffness and Serum Endocan Levels.
Türkuçar S; Yıldız K; Küme T; Açarı C; Dundar HA; Makay B; Kır M; Ünsal E
Clin Rheumatol; 2021 Oct; 40(10):4199-4206. PubMed ID: 33813620
[TBL] [Abstract][Full Text] [Related]
2. Arterial Stiffness and Ambulatory Blood Pressure Measurements in Children With Familial Mediterranean Fever.
Leventoğlu E; Büyükkaragöz B; Sunar Yayla EN; Esmeray Şenol P; Bakkaloğlu SA
Clin Pediatr (Phila); 2023 Nov; ():99228231211705. PubMed ID: 37937548
[TBL] [Abstract][Full Text] [Related]
3. Examination of cardiac functions during acute attack and remission period in children with familial Mediterranean fever.
Gunay Y; Karagozlu F; Gemici S; Yilmaz SS; Sahin S; Barut K; Kasapcopur O; Dedeoglu R
Eur J Pediatr; 2024 Jul; 183(7):3137-3145. PubMed ID: 38668795
[TBL] [Abstract][Full Text] [Related]
4. Assessment of serum neopterin and calprotectin as biomarkers for subclinical inflammation in patients with familial Mediterranean fever.
Tezcan D; Onmaz DE; Sivrikaya A; Hakbilen S; Körez MK; Gülcemal S; Yılmaz S
Ir J Med Sci; 2023 Aug; 192(4):2015-2022. PubMed ID: 36163581
[TBL] [Abstract][Full Text] [Related]
5. The assessment of fatigue and sleep quality among children and adolescents with familial Mediterranean fever: A case-control and correlation study.
İncesu Ç; Kayaalp GK; Demirkan FG; Köker O; Çakmak F; Akgün Ö; Ayaz NA; Ömeroğlu RN
Eur J Pediatr; 2024 May; 183(5):2223-2229. PubMed ID: 38393372
[TBL] [Abstract][Full Text] [Related]
6. Exploring S100A8/A9, Neopterin, and MMP3 in Familial Mediterranean Fever.
Kilinc OC; Akdeniz YS; Taskin Z; Karabulut M; Kaya A; Bolayırlı IM; Can G; Ugurlu S
Clin Exp Immunol; 2024 Jun; ():. PubMed ID: 38864482
[TBL] [Abstract][Full Text] [Related]
7. Role of serum calprotectin in identifying familial Mediterranean fever attacks.
Polat MG; Omma A; Gokcen N; Kilinckaya MF; Ozkan Karaahmetoglu S
Ir J Med Sci; 2024 Mar; ():. PubMed ID: 38478181
[TBL] [Abstract][Full Text] [Related]
8. Cardiac manifestations of Familial Mediterranean fever.
Alsarah A; Alsara O; Laird-Fick HS
Avicenna J Med; 2017; 7(4):158-163. PubMed ID: 29119082
[TBL] [Abstract][Full Text] [Related]
9. Serum endocan as a predictive biomarker of cardiovascular risk in obese pediatric patients.
Morace C; Curatola SL; Mandraffino G; Scuruchi M; Serrano' AE; Tropeano A; Lombardo F; Salzano G; Squadrito G; Versace AG; Valenzise M
Ital J Pediatr; 2023 Aug; 49(1):108. PubMed ID: 37653524
[TBL] [Abstract][Full Text] [Related]
10. Impact of multiple
Kishida D; Yazaki M; Nakamura A; Tsuchiya-Suzuki A; Ichikawa T; Shimojima Y; Sekijima Y
Immunol Med; 2024 May; ():1-6. PubMed ID: 38780575
[TBL] [Abstract][Full Text] [Related]
11. Correlation of Serum Endocan Level With Apoptosis Indicators and Severity of Atherosclerotic Lesions of Coronary Arteries in Patients With Coronary Heart Disease.
Zakharyan EA; Gritskevich OY; Ibragimova RE; Grigoriev PE
Kardiologiia; 2023 Dec; 63(11):12-20. PubMed ID: 38088108
[TBL] [Abstract][Full Text] [Related]
12. Hidden threat in familial Mediterranean fever: subclinical inflammation, oxidative stress and their relationship with vitamin D status.
Alesh MB; Keti DB; Kısaarslan AP; Muhtaroğlu S; Taşkın SN
Turk J Med Sci; 2022 Feb; 52(1):67-75. PubMed ID: 34544219
[TBL] [Abstract][Full Text] [Related]
13. The Relationship Between Endocan and Serum Inflammatory Markers in Patients with Senile Calcific Aortic Stenosis.
Akgün DE; Avcı E; Yaman A; Şafak Ö; Kısacık HL; Argan O; Yıldırım SE; Yıldırım T; Naser A; Gençbay M; Kırış T
Anatol J Cardiol; 2024 Jan; 28(2):102-8. PubMed ID: 38168010
[TBL] [Abstract][Full Text] [Related]
14. Relationship between endothelial dysfunction and microalbuminuria in familial Mediterranean fever.
Güneş H; Kıvrak T; Tatlısu M; Kaya H; Yılmaz MB
Eur J Rheumatol; 2016 Jun; 3(2):61-64. PubMed ID: 27708973
[TBL] [Abstract][Full Text] [Related]
15. New Biomarkers (Endocan, Interleukin-17, and Thrombospondin-4) for the Diagnosis, Assessment of Severity, and Follow-Up of Peripheral Arterial Disease.
Yazman S; Depboylu BC; Saruhan E; Cenikli U; Harmandar B; Arslan K; İlhan G; İştar H
Angiology; 2023 Aug; 74(7):631-639. PubMed ID: 37010303
[TBL] [Abstract][Full Text] [Related]
16. Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early life.
Kelishadi R
Open Cardiovasc Med J; 2010; 4():24-9. PubMed ID: 21804638
[TBL] [Abstract][Full Text] [Related]
17. Low-dose colchicine for chronic stable atherosclerosis: Under-appreciated and under-prescribed.
Ridker PM
Eur J Intern Med; 2024 May; ():. PubMed ID: 38762433
[No Abstract] [Full Text] [Related]
18. Familial Mediterranean fever (FMF)-response to TNF-blockers used for treatment of FMF patients with concurrent inflammatory diseases.
Haj-Yahia S; Ben-Zvi I; Lidar M; Livneh A
Joint Bone Spine; 2021 Oct; 88(5):105201. PubMed ID: 33932573
[TBL] [Abstract][Full Text] [Related]
19. The pyrin inflammasome aggravates inflammatory cell migration in patients with familial Mediterranean fever.
Akbaba TH; Akkaya-Ulum YZ; Demir S; Ozen S; Balci-Peynircioglu B
Pediatr Res; 2022 May; 91(6):1399-1404. PubMed ID: 33963299
[TBL] [Abstract][Full Text] [Related]
20. Pyrin Inflammasome Activation Abrogates Interleukin-1 Receptor Antagonist, Suggesting a New Mechanism Underlying Familial Mediterranean Fever Pathogenesis.
Mortensen SB; Hansen AE; Mogensen TH; Jakobsen MA; Beck HC; Harvald EB; Lambertsen KL; Johansen IS; Andersen DC
Arthritis Rheumatol; 2021 Nov; 73(11):2116-2126. PubMed ID: 33913256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
